Chapter 4887

While Williams and Eric were carrying out the investigation separately, the five major capital alliances continued to sweep Amgen Pharmaceuticals' stocks in the Bald Eagle stock market.

As long as the price of the sell order is right, the Vanguard Capital Group, which is responsible for this operation, will directly sweep in the stocks.

In the Bald Eagle stock market, there is a rule called the placard system, which roughly means that when a certain investor acquires more than 5% of the stocks, he needs to take the initiative to disclose the information.

Currently, the number of Amgen Pharmaceuticals' stocks acquired by Vanguard Capital Group has exceeded 35 million shares, and the total share capital of Amgen Pharmaceuticals is only 535.178.0 "zero six zero" 00 shares, which is equivalent to Vanguard Capital Group already holding 6.54% of Amgen Pharmaceuticals' equity.

According to the provisions of the placard system, Vanguard Capital Group should take the initiative to indicate that it is acquiring Amgen Pharmaceuticals' stocks.

However, how could Vanguard Capital Group make such a small mistake?

This time, the acquisition of Amgen Pharmaceuticals' stock was originally a joint action of the five major capital groups. How could it be possible to use only the resources of Vanguard Capital Group?

After the 6.54% of Amgen Pharmaceuticals' stock was operated by the five major capital groups, they were scattered in more than 100 accounts, and they could not reach the placard line at all.

When the five major capital groups were secretly acquiring Amgen Pharmaceuticals' stock, they found that Amgen Pharmaceuticals was investigating them.

Uriah Ross, senior vice president of investment at Vanguard Capital Group, directly initiated a voice conference through the dark web and pulled the other four senior vice presidents of investment into a temporary encrypted voice communication channel to communicate.

"Everyone, our actions have been discovered. Amgen Pharmaceuticals is investigating our acquisition. What do you think?" Uriah asked.

Barton of Morgan Investment Company spoke first, "I propose to postpone the acquisition and contact Amgen Pharmaceuticals' shareholders privately first, so as to acquire the shares held by the other party at a high premium."

Richard of Berkshire Hathaway seconded, "I support Barton this time. At present, the stock price of Amgen Pharmaceuticals has reached the $250 mark. If we continue to buy in large quantities in the market, I am afraid that the stock price will remain high."

Richard continued to add, "More importantly, our large-scale acquisition may cause others to pay special attention to Amgen Pharmaceuticals, and further speculate that the cooperation project between Amgen Pharmaceuticals and Anxin Life Sciences Group has a deep meaning."

Andy of Merrill Lynch Investment Company seconded, "I have no objection. I think Barton and Richard are right."

Finally, Francis of BlackRock Capital Group also agreed, "I have no objection, but I have one more thing to add."

Francis added, "We have to set a time to acquire Amgen Pharmaceuticals from shareholders.The time limit for the stock, once the time limit is over, regardless of whether we have successfully acquired the shares of Amgen Pharmaceutical Company shareholders, we must stop the action and re-enter the stock market to acquire shares. " Francis continued, "After entering the stock market for the second time, I suggest that we acquire Amgen Pharmaceutical Company's shares at all costs."

"I suspect that our actions have been guessed by the other side, and the other side has guessed the answer we guessed." Francis stated the reason for his proposal. I have to say that this guy is really smart! The other four did not refuse after listening to Francis's speech. They also agreed with Francis' analysis 0 ....... Uriah said affirmatively, "No problem, we will first try to obtain the corresponding equity from the shareholders of Amgen Pharmaceutical Company through over-the-counter transactions, and then acquire the corresponding stocks in the secondary market at all costs."

"Second!" Barton agreed. Richard agreed, "I agree. ”

Andy naturally did not refuse.

As the senior investment vice presidents of the five major investment institutions reached a consensus, the black hand that had swept Amgen Pharmaceuticals' stocks in the Bald Eagle stock market suddenly disappeared, which made some retail investors who placed sell orders at high prices confused.

Amgen Pharmaceuticals' president Williams was also confused. He had just started to investigate who was buying their Amgen stocks behind the scenes, but these people ran away?

There is a problem!

There is a 100% problem!

On the other hand, Vanguard Capital Group has arranged white gloves to contact relevant shareholders of Amgen Pharmaceuticals.

In a cafe 1.5 near Amgen Pharmaceuticals, Clara Pollitt was reading a fashion magazine. On the surface, she was an independent investor, but in fact, she was a white glove of Vanguard Capital Group, but few people knew it.

This time, Clara Pollitt's mission goal was to contact a female shareholder of Amgen Pharmaceuticals and try to acquire the other party's shares.

Clara likes to do such things. Although she is just a white glove of Vanguard Capital Group, as long as the mission is successful, she can get huge benefits.

So Clara is very concerned about the tasks arranged by Vanguard Capital Group! .